Where can I buy REVLIMID 25mg online?

Pharmacy Remedy provides genuine Bristol Myers Squibb REVLIMID 25mg capsules with international delivery. We supply hospitals, hematology centers, and distributors. Contact us via WhatsApp at +44 7429 917553 for wholesale pricing.

What is REVLIMID used for?

REVLIMID is FDA-approved for multiple myeloma (newly diagnosed and relapsed), maintenance therapy after stem cell transplant, myelodysplastic syndromes with deletion 5q, and mantle cell lymphoma. It's a cornerstone of modern myeloma treatment.

Why is REVLIMID used with dexamethasone?

REVLIMID and dexamethasone (Rd) is a synergistic combination. Dexamethasone provides direct anti-myeloma activity and enhances REVLIMID's effectiveness. This combination is the backbone of many myeloma regimens and can be combined with additional drugs like daratumumab.

What are the main side effects of REVLIMID?

Common side effects include low blood counts (neutropenia, thrombocytopenia, anemia), fatigue, diarrhea, constipation, rash, and muscle cramps. Serious risks include blood clots (require prophylaxis), infections, and second primary malignancies. Regular blood count monitoring is essential.

Why is REVLIMID restricted?

REVLIMID is teratogenic (causes severe birth defects) and available only through restricted distribution programs (REMS in USA). Strict pregnancy prevention is mandatory. All patients must be enrolled in the program and comply with requirements.

How long do patients take REVLIMID?

For myeloma, REVLIMID is typically continued until disease progression (continuous therapy has shown survival benefits). As maintenance after transplant, it may be taken for years. Treatment duration depends on response and tolerability.

REVLIMID

25mg

Oncology Medications

REVLIMID25mg

Name: REVLIMID 25mg
Brand: Bristol Myers
SKU: revlimid-25mg
Availability: InStock

REVLIMID (lenalidomide) 25mg is an immunomodulatory drug essential for treating multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma.

Generic Name:Lenalidomide

Manufacturer:Bristol Myers

Key Benefits

Cornerstone of modern multiple myeloma treatment
Immunomodulatory drug with multiple mechanisms
Oral administration—convenient home treatment
Proven survival benefits in clinical trials
Effective both as induction and maintenance
Works in newly diagnosed and relapsed disease

Contact Us for Pricing

Get competitive wholesale pricing for REVLIMID 25mg. Our team is available 24/7.

Direct line: +44 7429 917553

Licensed Supplier

Authorized pharmaceutical distributor

100% Original

Guaranteed authentic products

Worldwide Delivery

International shipping available

24/7 Support

WhatsApp support anytime

How REVLIMID Works

REVLIMID is an immunomodulatory agent with multiple mechanisms of action:

**Immunomodulation:** Enhances T-cell and NK-cell activity against cancer cells. Stimulates production of IL-2 and IFN-γ, key cytokines for anti-tumor immunity.

**Direct Anti-Tumor Effect:** Binds to cereblon (CRBN), causing ubiquitination and degradation of transcription factors IKZF1 and IKZF3, which are essential for myeloma cell survival.

**Anti-Angiogenesis:** Inhibits VEGF and bFGF, reducing blood vessel formation that tumors need to grow.

**Microenvironment Disruption:** Decreases production of pro-inflammatory cytokines (TNF-α, IL-6) that support myeloma cell growth in the bone marrow.

This multi-targeted approach explains why REVLIMID is effective as both induction therapy and long-term maintenance, providing durable disease control.

About REVLIMID 25mg

REVLIMID (lenalidomide) 25mg by Bristol Myers Squibb (formerly Celgene) is a cornerstone immunomodulatory drug (IMiD) that has revolutionized multiple myeloma treatment. As the successor to thalidomide with improved efficacy and safety, REVLIMID has become an essential component of nearly every myeloma treatment regimen. REVLIMID works through multiple mechanisms: enhancing immune function, directly killing cancer cells, inhibiting angiogenesis, and modulating the bone marrow microenvironment. This multi-pronged action makes it remarkably effective against myeloma. REVLIMID is FDA-approved for multiple myeloma (in combination regimens for newly diagnosed and relapsed/refractory disease), maintenance therapy after autologous stem cell transplant, myelodysplastic syndromes with deletion 5q abnormality, and mantle cell lymphoma after two prior therapies. The FIRST trial demonstrated that continuous REVLIMID plus dexamethasone until progression significantly improved progression-free survival compared to fixed-duration chemotherapy. We provide authentic Bristol Myers Squibb REVLIMID for hematology/oncology centers and distributors worldwide.

Common Uses

Multiple myeloma combination therapy
Myeloma maintenance after transplant
Myelodysplastic syndromes with del(5q)
Mantle cell lymphoma (relapsed/refractory)
Rd, VRd, DRd, KRd combination regimens

Dosage Information

Multiple Myeloma (with dexamethasone):

25 mg orally once daily on Days 1-21 of 28-day cycle

Continue until disease progression

Maintenance After Transplant:

10 mg once daily on Days 1-28 of 28-day cycles

After 3 cycles, increase to 15 mg daily if tolerated

MDS with del(5q):

10 mg orally once daily

Mantle Cell Lymphoma:

25 mg once daily on Days 1-21 of 28-day cycle

Dose Modifications:

Based on blood counts (neutrophils, platelets)

Reduce for renal impairment

**CRITICAL:** REVLIMID is teratogenic. Available only through REMS program. Pregnancy prevention mandatory.

Always consult with a qualified healthcare professional for proper dosing. This information is for reference only.

Storage & Handling

Store REVLIMID capsules at 20°C to 25°C (68°F to 77°F). Excursions permitted between 15°C and 30°C (59°F and 86°F). Store in original packaging. No cold chain required.

We ensure proper cold chain handling during shipping to maintain product integrity.